{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:01Z","timestamp":1792081501717,"version":"4.4.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014379","name":"Canadian Network for Mood and Anxiety Treatments","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jad.2009.06.041","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T05:46:36Z","timestamp":1250055996000},"page":"S26-S43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":326,"special_numbering":"S1","title":["Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults."],"prefix":"10.1016","volume":"117","author":[{"given":"Raymond W.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajamannar","family":"Ramasubbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun V.","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2009.06.041_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0033291799001270","article-title":"Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies","volume":"30","author":"Addis","year":"2000","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JGP.0b013e31813546f2","article-title":"Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression","volume":"16","author":"Alexopoulos","year":"2008","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/57.1.161","article-title":"Meta-analytical studies on new antidepressants","volume":"57","author":"Anderson","year":"2001","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jad.2009.06.041_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0269881107088441","article-title":"Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines","volume":"22","author":"Anderson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2009.06.041_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4088\/JCP.v62n0608","article-title":"Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study","volume":"62","author":"Appelberg","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1461145705006358","article-title":"Discontinuation symptoms in depression and anxiety disorders","volume":"10","author":"Baldwin","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1503\/cmaj.081514","article-title":"Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies","volume":"180","author":"Barbui","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2009.06.041_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","article-title":"Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors","volume":"29","author":"Bar-Oz","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2009.06.041_bib10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1176\/appi.ajp.157.9.1429","article-title":"Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression","volume":"157","author":"Bauer","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4088\/JCP.v65n0911","article-title":"Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: infant exposure, clinical symptoms, and cytochrome p450 genotypes","volume":"65","author":"Berle","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Berman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2125.2007.03052.x","article-title":"Influence of the CYP2D6*4 polymorphism on dose, switching and discontinuation of antidepressants","volume":"65","author":"Bijl","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2005-837806","article-title":"Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data","volume":"38","author":"Brambilla","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2009.06.041_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09540260801889245","article-title":"The contribution of pharmacoepidemiology to the antidepressant-suicidality debate in children and adolescents","volume":"20","author":"Bridge","year":"2008","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2009.06.041_bib19","first-page":"CD006722","article-title":"Psychostimulants for depression","volume":"2","author":"Candy","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2009.06.041_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jad.2009.06.041_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib23","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4088\/JCP.v69n1108","article-title":"Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis","volume":"69","author":"Cipriani","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2009.06.041_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S1461145707008206","article-title":"Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors","volume":"11","author":"Cooper-Kazaz","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4088\/JCP.v68n0617","article-title":"Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials","volume":"68","author":"Crossley","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.08m04592","article-title":"Extended release quetiapine fumerate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study","volume":"70","author":"Cutler","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1586\/14737175.6.1.73","article-title":"Current and emerging somatic treatment strategies in psychotic major depression","volume":"6","author":"Dannon","year":"2006","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jad.2009.06.041_bib29","series-title":"Program and abstracts of the American Psychiatric Association 161st Annual Meeting; May 3-8, 2008; Washington, DC, Abstract NR3-017","article-title":"Double blind study of extended release quetiapine fumarate XR monotherapy for maintenance treatment of MDD (abstract)","author":"Datto","year":"2008"},{"key":"10.1016\/j.jad.2009.06.041_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0447.2005.00678.x","article-title":"Use of antidepressant combinations: which, when and why? Results of a Spanish survey","volume":"428","author":"de la Gandara","year":"2005","journal-title":"Acta Psychiatr. Scand., Suppl."},{"key":"10.1016\/j.jad.2009.06.041_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1503\/cmaj.061533","article-title":"Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose","volume":"176","author":"Deshauer","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2009.06.041_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2005.08.012","article-title":"To combine or not to combine? A literature review of antidepressant combination therapy","volume":"89","author":"Dodd","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.bp.105.011833","article-title":"Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis","volume":"189","author":"Dubicka","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00023210-200620030-00002","article-title":"Use of psychotropic medications in treating mood disorders during lactation: practical recommendations","volume":"20","author":"Eberhard-Gran","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2009.06.041_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pds.1084","article-title":"Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies","volume":"14","author":"Einarson","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2009.06.041_bib36","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/01.chi.0000240840.63737.1d","article-title":"Treatment for Adolescents with Depression Study (TADS): safety results","volume":"45","author":"Emslie","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.jad.2009.06.041_bib37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4088\/JCP.v62n1106","article-title":"Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo","volume":"62","author":"Entsuah","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00126839-200506060-00002","article-title":"Antidepressant drug\u2013drug interaction profile update","volume":"6","author":"Ereshefsky","year":"2005","journal-title":"Drugs R & D"},{"key":"10.1016\/j.jad.2009.06.041_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-200208000-00008","article-title":"Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine","volume":"22","author":"Fava","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","article-title":"Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder","volume":"59","author":"Fava","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10401230701464858","article-title":"Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness","volume":"19","author":"Fava","year":"2007","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0447.2001.00148.x","article-title":"Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone","volume":"103","author":"Ferreri","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2009.06.041_bib43","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMp078015","article-title":"Expanding the black box \u2013 depression, antidepressants, and the risk of suicide","volume":"356","author":"Friedman","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib44","series-title":"Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression","author":"Gartlehner","year":"2007"},{"key":"10.1016\/j.jad.2009.06.041_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00002018-200831100-00004","article-title":"Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis","volume":"31","author":"Gartlehner","year":"2008","journal-title":"Drug Safety"},{"key":"10.1016\/j.jad.2009.06.041_bib46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0140-6736(03)12599-8","article-title":"Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review","volume":"361","author":"Geddes","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2009.06.041_bib47","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/appi.ajp.2007.07030454","article-title":"Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents","volume":"164","author":"Gibbons","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.39224.494340.55","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial","volume":"335","author":"Goodyer","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2009.06.041_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JCP.0b013e31802eb4a3","article-title":"Sex differences in antidepressant response in a Canadian primary-care sample","volume":"27","author":"Grigoriadis","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.330.7488.385","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review","volume":"330","author":"Gunnell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2009.06.041_bib51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in pediatric patients treated with antidepressant drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.jcp.0000203198.11453.95","article-title":"Suicide rates in short-term randomized controlled trials of newer antidepressants","volume":"26","author":"Hammad","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-143-6-200509200-00006","article-title":"Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder","volume":"143","author":"Hansen","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib54","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1176\/ps.2008.59.10.1121","article-title":"Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants","volume":"59","author":"Hansen","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2009.06.041_bib55","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.310.6984.897","article-title":"Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis [see comments]","volume":"310","author":"Hazell","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2009.06.041_bib56","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mcp.2002.126181","article-title":"Citalopram in pregnancy and lactation","volume":"72","author":"Heikkinen","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2009.06.041_bib57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1345\/aph.1E547","article-title":"Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis","volume":"39","author":"Hemels","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jad.2009.06.041_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4088\/JCP.v64n0409","article-title":"Weight gain in breastfed infants of mothers taking antidepressant medications","volume":"64","author":"Hendrick","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib59","first-page":"CD004851","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents","volume":"3","author":"Hetrick","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2009.06.041_bib60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11414-007-9070-6","article-title":"Discontinuation of antidepressant medication among Latinos in the USA","volume":"34","author":"Hodgkin","year":"2007","journal-title":"J Behav. Health Serv. Res."},{"key":"10.1016\/j.jad.2009.06.041_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/10398560601109855","article-title":"A survey of combination antidepressant use in Australia","volume":"15","author":"Horgan","year":"2007","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2008.08.010","article-title":"Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome","volume":"99","author":"Howland","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2009.06.041_bib147","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pnpbp.2007.09.003","article-title":"ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder","volume":"32","author":"Kato","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1503\/cmaj.071265","article-title":"Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults","volume":"178","author":"Katz","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2009.06.041_bib64","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.4088\/JCP.v68n0812","article-title":"The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the 2-year and combined maintenance phases","volume":"68","author":"Keller","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib65","series-title":"Clinical guidelines for the treatment of depressive disorders","first-page":"1S","volume":"46","year":"2001"},{"key":"10.1016\/j.jad.2009.06.041_bib66","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1177\/070674372001460101004","article-title":"Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.","volume":"46","author":"Kennedy","year":"2001","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib67","series-title":"Treating Depression Effectively","author":"Kennedy","year":"2007"},{"key":"10.1016\/j.jad.2009.06.041_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1185\/03007990802622726","article-title":"Escitalopram in the treatment of major depressive disorder: a meta-analysis","volume":"25","author":"Kennedy","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2009.06.041_bib69","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jad.2009.06.043","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the treatment of management of major depressive disorder in adults","volume":"117","author":"Kennedy","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib70","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.jad.2009.06.039","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies","volume":"117","author":"Kennedy","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib71","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.jcp.0000168879.03169.ce","article-title":"Sex differences in antidepressant response in recent antidepressant clinical trials","volume":"25","author":"Khan","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib72","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4088\/JCP.v67n0510","article-title":"Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials","volume":"67","author":"Kornstein","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib73","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2105\/AJPH.2006.087262","article-title":"The effect of antidepressant warnings on prescribing trends in Ontario, Canada","volume":"97","author":"Kurdyak","year":"2007","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jad.2009.06.041_bib74","first-page":"1","article-title":"Prescribing antidepressants for depression in 2005: recent concerns and recommendations","volume":"49","author":"Lam","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib75","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.jp.7211352","article-title":"Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis","volume":"25","author":"Lattimore","year":"2005","journal-title":"J. Perinatol."},{"key":"10.1016\/j.jad.2009.06.041_bib76","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1176\/ajp.2007.164.6.884","article-title":"Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs","volume":"164","author":"Libby","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00213-002-0999-0","article-title":"Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation","volume":"161","author":"Licht","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jad.2009.06.041_bib78","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.npp.1300571","article-title":"Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy","volume":"30","author":"Lieberman","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2009.06.041_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2007.03541.x","article-title":"Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs","volume":"27","author":"Loke","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2009.06.041_bib80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11920-008-0041-2","article-title":"Medically serious adverse effects of newer antidepressants","volume":"10","author":"Mago","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2009.06.041_bib81","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-147-9-200711060-00003","article-title":"Risperidone for treatment-refractory major depressive disorder: a randomized trial","volume":"147","author":"Mahmoud","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib82","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"Marcus","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib83","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/ajp.2006.163.9.1531","article-title":"Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report","volume":"163","author":"McGrath","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib84","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14740338.5.4.523","article-title":"The effect of antidepressants on lipid homeostasis: a cardiac safety concern?","volume":"5","author":"McIntyre","year":"2006","journal-title":"Expert Opin Drug Safety"},{"key":"10.1016\/j.jad.2009.06.041_bib85","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/503820","article-title":"Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment","volume":"78","author":"McMahon","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jad.2009.06.041_bib86","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/070674370004500509","article-title":"Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians","volume":"45","author":"Mischoulon","year":"2000","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib87","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.4088\/JCP.v65n0913","article-title":"The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial","volume":"65","author":"Misri","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib88","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biopsych.2005.07.021","article-title":"Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL","volume":"58","author":"Modell","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib89","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00406-006-0689-8","article-title":"Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review","volume":"256","author":"Moller","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2009.06.041_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00406-008-3002-1","article-title":"Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.","volume":"258","author":"Moller","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2009.06.041_bib91","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1368-5031.2005.00731.x","article-title":"Antidepressants and seizures: emphasis on newer agents and clinical implications","volume":"59","author":"Montgomery","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jad.2009.06.041_bib92","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/YIC.0b013e3282eff7e0","article-title":"Which antidepressants have demonstrated superior efficacy? A review of the evidence","volume":"22","author":"Montgomery","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/cap.2006.16.25","article-title":"Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis","volume":"16","author":"Mosholder","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-0327(02)00083-6","article-title":"Age may affect response to antidepressants with serotonergic and noradrenergic actions","volume":"76","author":"Mulder","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib95","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2165\/00002018-200528120-00009","article-title":"Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK","volume":"28","author":"Murray","year":"2005","journal-title":"Drug Safety"},{"key":"10.1016\/j.jad.2009.06.041_bib96","series-title":"Clinical Guideline 23","article-title":"Depression: management of depression in primary and secondary care","year":"2004"},{"key":"10.1016\/j.jad.2009.06.041_bib97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2007.06.027","article-title":"Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs","volume":"63","author":"Nemeroff","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00004714-200302000-00013","article-title":"Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants","volume":"23","author":"Nierenberg","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib99","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/ajp.2006.163.9.1519","article-title":"A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report","volume":"163","author":"Nierenberg","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/070674370605100506","article-title":"Systematic overview of drug interactions with antidepressant medications","volume":"51","author":"Nieuwstraten","year":"2006","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib101","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1701-2163(16)32918-8","article-title":"Does paroxetine cause cardiac malformations?","volume":"30","author":"O'Brien","year":"2008","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.jad.2009.06.041_bib102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/appi.ajp.163.1.101","article-title":"Continuity of antidepressant treatment for adults with depression in the United States","volume":"163","author":"Olfson","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib103","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000195042.62724.76","article-title":"A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder","volume":"26","author":"Papakostas","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib104","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/YIC.0b013e32819f8400","article-title":"Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions","volume":"22","author":"Papakostas","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000104702","article-title":"Antidepressant dose reduction and the risk of relapse in major depressive disorder","volume":"76","author":"Papakostas","year":"2007","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2009.06.041_bib106","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4088\/JCP.v68n0602","article-title":"Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis","volume":"68","author":"Papakostas","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib107","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.biopsych.2007.08.010","article-title":"Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches","volume":"63","author":"Papakostas","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib108","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jad.2009.06.042","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication","volume":"117","author":"Parikh","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jad.2009.06.041_bib109","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.jcp.0000246212.03530.fd","article-title":"A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression","volume":"26","author":"Patkar","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib110","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jad.2009.06.044","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the treatment of management of major depressive disorder in adults. I. Classification, burden and principles of management","volume":"117","author":"Patten","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib111","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4088\/JCP.v65n0215","article-title":"Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial","volume":"65","author":"Perry","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib112","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4088\/JCP.v66n0201","article-title":"Is there a delay in the antidepressant effect? A meta-analysis","volume":"66","author":"Posternak","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib113","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00131746-200609000-00006","article-title":"Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II","volume":"12","author":"Preskorn","year":"2006","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2009.06.041_bib114","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.reprotox.2006.03.019","article-title":"Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials","volume":"22","author":"Rahimi","year":"2006","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.jad.2009.06.041_bib115","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301113","article-title":"Effects of risperidone augmentation in patients with treatment-resistant depression: results of open-label treatment followed by double-blind continuation","volume":"31","author":"Rapaport","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2009.06.041_bib116","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v69n0112","article-title":"Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial","volume":"69","author":"Ravindran","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib118","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJMoa052619","article-title":"Maintenance treatment of major depression in old age","volume":"354","author":"Reynolds","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib119","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4088\/JCP.v67n1203","article-title":"Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review","volume":"67","author":"Ruhe","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.jad.2009.06.041_bib121","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression","volume":"354","author":"Rush","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib122","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S1461145707008255","article-title":"Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence","volume":"10","author":"Sartorius","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib123","first-page":"27","article-title":"Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research","volume":"67","author":"Schatzberg","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib148","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib124","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4065\/81.3.330","article-title":"Anticipating potential linezolid\u2013SSRI interactions in the general hospital setting: an MAOI in disguise","volume":"81","author":"Sola","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jad.2009.06.041_bib125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","article-title":"Psychotropic medications and the risk of fracture: a meta-analysis","volume":"30","author":"Takkouche","year":"2007","journal-title":"Drug Safety"},{"key":"10.1016\/j.jad.2009.06.041_bib126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jad.2005.07.006","article-title":"Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials","volume":"88","author":"Taylor","year":"2005","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib127","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","article-title":"Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis","volume":"63","author":"Taylor","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib128","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/GIM.0b013e31815bf98f","article-title":"Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors","volume":"9","author":"Thakur","year":"2007","journal-title":"Genet. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib129","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.v68n0207","article-title":"A randomized, double-blind comparison of olanzapine\/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder","volume":"68","author":"Thase","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib130","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2009.06.041_bib131","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib132","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/sj.npp.1301390","article-title":"Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care","volume":"32","author":"Trivedi","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2009.06.041_bib133","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1192\/bjp.bp.106.031088","article-title":"Efficacy of antidepressants in juvenile depression: meta-analysis","volume":"193","author":"Tsapakis","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib134","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.euroneuro.2007.06.001","article-title":"Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis","volume":"18","author":"Usala","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib135","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1185\/030079906X148319","article-title":"The onset of effect for escitalopram and its relevance for the clinical management of depression","volume":"22","author":"Wade","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2009.06.041_bib136","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/cap.2006.16.37","article-title":"A cumulative meta-analysis of selective serotonin reuptake inhibitors in pediatric depression: did unpublished studies influence the efficacy\/safety debate?","volume":"16","author":"Wallace","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib137","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2009.06.041_bib138","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","article-title":"Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants","volume":"161","author":"Weissman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib139","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bmj.39462.375613.BE","article-title":"The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study","volume":"336","author":"Wheeler","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2009.06.041_bib140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.bp.105.010470","article-title":"Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis","volume":"188","author":"Wijkstra","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib141","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4088\/JCP.v62n0202","article-title":"Prevention of recurrent postpartum depression: a randomized clinical trial","volume":"62","author":"Wisner","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib142","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1176\/appi.ajp.161.7.1290","article-title":"Prevention of postpartum depression: a pilot randomized clinical trial","volume":"161","author":"Wisner","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib143","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.jcp.0000227706.56870.dd","article-title":"Postpartum depression: a randomized trial of sertraline versus nortriptyline","volume":"26","author":"Wisner","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2009.06.041_bib144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2009.06.041_bib145","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4088\/JCP.v69n0420","article-title":"Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine","volume":"69","author":"Yonkers","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2009.06.041_bib146","series-title":"Sex differences in response to citalopram: a STAR *D report","author":"Young","year":"2008"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709003309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032709003309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:08:23Z","timestamp":1759021703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032709003309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":147,"alternative-id":["S0165032709003309"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2009.06.041","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2009.06.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}